In this episode of AHLA's monthly series on fraud and abuse issues, Matthew Wetzel, Partner, Goodwin Procter, speaks to Todd Nova, Shareholder, Hall Render, about issues related to the 340B drug discount program. They discuss discrepancies in how federal courts are interpreting the program’s requirements around contract pharmacies, issues related to drug diversion and duplicate discounts, legislative and regulatory developments, and predictions for 2022 and beyond. From AHLA's Fraud and Abuse Practice Group. Sponsored by BRG.Essential Legal Updates, Now in Audio AHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Premium members. Get all your health law news from the major media outlets on this podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast. Stay At the Forefront of Health Legal Education Learn more about AHLA and the educational resources available to the health law community at https://www.americanhealthlaw.org/.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.